Cannabinoid-1-Rezeptor-Antagonist -Rimonabant- effects of state of health and quality of life by obesity patients

Doctoral thesis German OPEN
Knispel, Edelgard (2010)
  • Publisher: Freie Universität Berlin Universitätsbibliothek, Garystr. 39, 14195 Berlin
  • Subject: 610 Medizin und Gesundheit | 610 Medical sciences; Medicine
    • ddc: ddc:610

Background: 4 double-blind, placebo-controlled clinical phase III trials of the RIO (Rimona-bant in Obesity)-programme indicated that rimonabant, a selective cannabinoid-1 (CB1) re-ceptor blocker, promoted significant decrease of bodyweight and waist circumference in ov... View more
Share - Bookmark